Wen Leana
UroGen Pharma Ltd. · Director
Wen Leana is listed in filings as Director at UroGen Pharma Ltd.. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity. Recent filings connect the profile to UroGen Pharma Ltd. (URGN) and Glaukos Corporation (GKOS). The current snapshot covers public activity from Aug 8, 2024 to Jun 24, 2026. Reported amounts are shown as $349.9K to $195.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $244k1.7k shares | SellMay 1, 2026 | $143.35 | $109.88 |